Microarrays, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Microarrays, Inc. - overview

Established

1999

Location

Huntsville, AL, US

Primary Industry

Biotechnology

About

Based in Alabama, US, and founded in 1999 by its CEO Joel Peek, Microarrays, Inc. operates as a biotechnology company that specializes in the development and production of microarray-based diagnostic and research tools. In March 2023, Spectrum Solutions, a healthcare solutions partner, and a portfolio company of DW Healthcare Partners, acquired Microarrays, Inc. Microarrays, Inc.


offers complete laboratory services for gene expression microarray assays using MI DNA Microarray and hybridization methods and technologies; MI PathArray assays focus on area-specific pathways in development and disease, bringing microarray sensitivity to research; protein arrays provide specialized services such as reduced temperature printing conditions, proprietary solubilization buffers, ranging deposition volumes, functional QC, and product validation; DNA arrays for high-throughput genotyping, gene expression analysis, and epigenetics research; Assay Development.


Current Investors

Spectrum Solutions

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biotechnology

Website

www.microarrays.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Microarrays, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedMicroarrays, Inc.-

Displaying 1 - 1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.